Table 1. Demographic and epidemiologic characteristics of patients with monkeypox in Marseille during the 2022 outbreak in southern France*.
| Variable | No. patients† |
|---|---|
| Age, y, median (IQR) |
36 (30–42) |
| Sex | |
| F | 3 (2.2) |
| M |
133 (97.8) |
| Sexual orientation | |
| Men who have sex with men | 125 (91.9) |
| Using PrEP | 30 (24) |
| Heterosexual men | 2 (1.5) |
| Heterosexual women |
3 (2.2) |
| History of smallpox vaccination | |
| Childhood vaccine | 7 (5.1) |
| Postexposure vaccine | 6 (4.4) |
| Preexposure vaccine |
2 (1.5) |
| HIV-positive | |
| Total | 21 (15.4) |
| <500 CD4/mm3 | 5 (23.8) |
| <200 CD4/mm3 |
0 |
| Possible exposure to monkeypox | |
| Sexual partner with monkeypox | 21 (15.4) |
| New sexual partners‡ | 115 (84.6) |
| Attendance at a Pride event | 7 (5.2) |
| Recent travel to an endemic country | 0 |
| Recent travel to an epidemic country | 17 (12.5) |
*Values are no. (%) patients except as indicated. PrEP, preexposure prophylaxis; CD4, CD4 T lymphocyte. †Total number of patients in the study was 136. ‡Single or multiple new sexual partners in the previous 21 d.